Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance

Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	David W. Wareham, David C. Bean, Priyanka Khanna, Enid Hennessy, D. Krahé, A. Ely, M. Millar
Hōputu:	Artigo
Reo:	Ingarihi
I whakaputaina:	2008
Urunga tuihono:	https://doi.org/10.1007/s10096-008-0473-y https://link.springer.com/content/pdf/10.1007/s10096-008-0473-y.pdf
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite

Comparison of colistin monotherapy and non-colistin combinations in the treatment of multi-drug resistant Acinetobacter spp. bloodstream infections: A Multicenter retrospective analysis
mā: Balkan, Ilker Inanc, me ētahi atu.
I whakaputaina: (2015)

Bloodstream infections due to Peptoniphilus spp.: report of 15 cases
mā: Brown, K, me ētahi atu.
I whakaputaina: (2014)

Bloodstream infections due to Peptoniphilus spp.: report of 15 cases
mā: Kristen Brown, me ētahi atu.
I whakaputaina: (2014)

Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features
mā: Almasaudi, Saad B.
I whakaputaina: (2018)

Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features
mā: Saad B. Almasaudi
I whakaputaina: (2016)

Epidemiology of Bloodstream Infections Caused by Acinetobacter baumannii and Impact of Drug Resistance to both Carbapenems and Ampicillin-Sulbactam on Clinical Outcomes
mā: Chopra, Teena, me ētahi atu.
I whakaputaina: (2013)

Epidemiology of Bloodstream Infections Caused by Acinetobacter baumannii and Impact of Drug Resistance to both Carbapenems and Ampicillin-Sulbactam on Clinical Outcomes
mā: Teena Chopra, me ētahi atu.
I whakaputaina: (2013)

Characterization and molecular epidemiology of extensively prevalent nosocomial isolates of drug-resistant Acinetobacter spp
mā: Andreia Carvalho, me ētahi atu.
I whakaputaina: (2016)

Emergence of multi drug resistant nonfermentative Acinetobacter spp in a tertiary care hospital
mā: Amol, Shyamkuwar, me ētahi atu.
I whakaputaina: (2012)

Risk Factors and Outcomes for Patients with Bloodstream Infection Due to Acinetobacter baumannii-calcoaceticus Complex
mā: Chopra, Teena, me ētahi atu.
I whakaputaina: (2014)

Risk Factors and Outcomes for Patients with Bloodstream Infection Due to Acinetobacter baumannii-calcoaceticus Complex
mā: Teena Chopra, me ētahi atu.
I whakaputaina: (2014)

Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.
mā: Bergogne-Bérézin, E, me ētahi atu.
I whakaputaina: (1996)

Epidemiology and Infection Control Implications of Acinetobacter spp. in Hong Kong
mā: Houang, Elizabeth T. S., me ētahi atu.
I whakaputaina: (2001)

Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features
mā: E Bergogne-Bérézin, me ētahi atu.
I whakaputaina: (1996)

Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.
mā: Eugenie Bergogne‐Berezin, me ētahi atu.
I whakaputaina: (1996)

Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005 – 2006
mā: Bean, David C, me ētahi atu.
I whakaputaina: (2008)

Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005 – 2006
mā: David C. Bean, me ētahi atu.
I whakaputaina: (2008)

Epidemiological impact of the antimicrobial therapy on Acinetobacter spp. isolated from ITU patients
mā: Nikodemski, T, me ētahi atu.
I whakaputaina: (1998)

Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii
mā: Niu, Tianshui, me ētahi atu.
I whakaputaina: (2019)

Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii
mā: Tianshui Niu, me ētahi atu.
I whakaputaina: (2019)

Epidemiology, species distribution and outcome of nosocomial Candida spp. bloodstream infection in Shanghai
mā: Yang, Zhi-Tao, me ētahi atu.
I whakaputaina: (2014)

Epidemiology, species distribution and outcome of nosocomial Candida spp.bloodstream infection in Shanghai
mā: Zhitao Yang, me ētahi atu.
I whakaputaina: (2014)

Molecular Epidemiology of Multi-Drug Resistant Acinetobacter baumannii Isolated in Shandong, China
mā: Jiang, Meijie, me ētahi atu.
I whakaputaina: (2016)

In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases
mā: Wareham, David W, me ētahi atu.
I whakaputaina: (2006)

In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases.
mā: David W. Wareham, me ētahi atu.
I whakaputaina: (2006)

Risk factors to bloodstream infection due multidrug-resistant Results Acinetobacter baumanni in colonized patients in the ICU
mā: Passos, R, me ētahi atu.
I whakaputaina: (2011)

Risk factors to bloodstream infection due multidrug-resistant Results Acinetobacter baumanni in colonized patients in the ICU
mā: Rogério da Hora Passos, me ētahi atu.
I whakaputaina: (2011)

Shewanella spp. Bloodstream Infections in Queensland, Australia
mā: Laupland, Kevin B., me ētahi atu.
I whakaputaina: (2022)

Acinetobacter spp. Infections in Malaysia: A Review of Antimicrobial Resistance Trends, Mechanisms and Epidemiology
mā: Mohd. Rani, Farahiyah, me ētahi atu.
I whakaputaina: (2017)

In Vitro Activities of Polymyxin B, Imipenem, and Rifampin against Multidrug-Resistant Acinetobacter baumannii
mā: Wareham, D. W., me ētahi atu.
I whakaputaina: (2006)

Molecular Epidemiology of Aminoglycosides Resistance in Acinetobacter Spp. with Emergence of Multidrug-Resistant Strains
mā: Moniri, R, me ētahi atu.
I whakaputaina: (2010)

Epidemiology and Infection Control Implications of <i>Acinetobacter</i> spp. in Hong Kong
mā: Elizabeth T. S. Houang, me ētahi atu.
I whakaputaina: (2001)

Acinetobacter spp. in Gunshot Injuries
mā: Elston, James W.T., me ētahi atu.
I whakaputaina: (2008)

An ionophore breaks the multi-drug-resistance of Acinetobacter baumannii
mā: De Oliveira, David M.P., me ētahi atu.
I whakaputaina: (2022)

Catheter-related bloodstream infection due to Acinetobacter ursingii in a hemodialysis patient: case report and literature review
mā: Daniel, Arsanios Martin, me ētahi atu.
I whakaputaina: (2021)

Effect of Inhaled Colistin on the Treatment of Ventilator-Associated Pneumonia due to Multi-drug Resistant Acinetobacter
mā: Moradi Moghaddam, Omid, me ētahi atu.
I whakaputaina: (2019)

Bloodstream infection by Acinetobacter radioresistens: the first case report in Brazil
mā: Lopes, Maria Carolina, me ētahi atu.
I whakaputaina: (2020)

Bloodstream infection by Acinetobacter radioresistens: the first case report in Brazil
mā: Maria Carolina Soares Lopes, me ētahi atu.
I whakaputaina: (2019)

Molecular Epidemiology of Clinical Isolates of Carbapenem-Resistant Acinetobacter spp. from Chinese Hospitals
mā: Wang, Hui, me ētahi atu.
I whakaputaina: (2007)

Longitudinal Epidemiology of Multidrug Resistant (MDR) Acinetobacter spp. in a Tertiary-Care Hospital
mā: Baang, Ji Hoon, me ētahi atu.
I whakaputaina: (2011)